Vangacin 500/Vangacin 1 g

Vangacin 500/Vangacin 1 g Indications/Uses



Able Medical


Universal Medical Industry


Able Medical
Full Prescribing Info
Endocarditis: Diphtheroid: For the treatment of diphtheroid endocarditis. Vancomycin has been used successfully in combination with either rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diphtheroids.
Enterococcal: For endocarditis caused by enterococci (eg, Enterococcus faecalis), vancomycin has been reported to be effective only in combination with an aminoglycoside.
Staphylococcal: In the treatment of staphylococcal endocarditis.
Streptococcal: Alone or in combination with aminoglycoside for endocarditis caused by Streptococcus viridans or Streptococcus bovis.
Clostridium difficile-associated diarrhea/staphylococcal enterocolitis: Certain parenteral products of vancomycin may be administered orally for treatment of C. difficile-associated diarrhea and for staphylococcal enterocolitis. Parenteral administration of vancomycin alone is of unproven benefit for these indications. Vancomycin is not effective by the oral route for other types of infection.
Staphylococcal infections: For the treatment of serious or severe infection caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. It is indicated for patients who are allergic to penicillin; for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins; and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, adjust therapy accordingly.
Its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, and skin and skin structure infections. When staphylococcal infections are localized and purulent, antibiotics are used as adjuncts to appropriate surgical measures.
Vancomycin is recommended for the treatment of mild, moderate, and severe Clostridium difficile infections in pregnant women.
Vancomycin is recommended as an alternative agent to prevent the transmission of group B streptococcal (GBS) disease from mothers to newborns.
Vancomycin is used for prevention of bacterial endocarditis. It is used as an alternative agent for prevention of enterococcal endocarditis in penicillin-allergic adults and children with congenital heart disease, rheumatic or other acquired valvular heart dysfunction, prosthetic heart valves, who undergo certain GI, biliary tract, or genitourinary surgery of instrumentation likely to cause transient bacteremia and increase the risk of endocarditis. The AHA recognizes that its current recommendations for prophylaxis against bacterial endocarditis are empiric, since no controlled efficacy studies have been published. However, the AHA generally recommend routine use for prophylactic anti-infectives in patients with the cardiac conditions described previously since these are associated with a high or moderate risk for bacterial endocarditis.
Prophylaxis against infective endocarditis: Dental, oral, or upper respiratory tract surgery. American Heart Associate (AHA) guidelines recommend prophylaxis only in patients undergoing invasive procedures and in whom underlying cardiac conditions may predispose to a higher risk of adverse outcomes should infection occur.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in